Edition:
India

ADMA Biologics Inc (ADMA.OQ)

ADMA.OQ on NASDAQ Stock Exchange Capital Market

2.87USD
20 Nov 2017
Change (% chg)

-- (--)
Prev Close
$2.87
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
24,837
52-wk High
$6.10
52-wk Low
$2.02

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.33 December 21 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 2 2 2
(3) HOLD 0 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 3 7.54 8.40 6.38 6.63
Quarter Ending Mar-18 1 6.55 6.55 6.55 4.35
Year Ending Dec-17 3 18.85 20.80 17.14 16.61
Year Ending Dec-18 3 37.88 47.32 28.31 40.46
Earnings (per share)
Quarter Ending Dec-17 3 -0.33 -0.20 -0.48 -0.15
Quarter Ending Mar-18 1 -0.26 -0.26 -0.26 -0.25
Year Ending Dec-17 3 -1.83 -1.67 -2.07 -1.14
Year Ending Dec-18 3 -1.08 -0.64 -1.67 -0.56

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 6.46 4.73 1.74 26.84
Quarter Ending Jun-17 3.26 3.40 0.14 4.34
Quarter Ending Mar-17 2.96 2.63 0.34 11.32
Quarter Ending Dec-16 2.91 3.33 0.41 14.17
Quarter Ending Sep-16 2.38 2.94 0.55 23.19
Earnings (per share)
Quarter Ending Sep-17 -0.42 -0.58 0.16 -37.02
Quarter Ending Jun-17 -0.25 -0.55 0.30 -115.69
Quarter Ending Mar-17 -0.28 -0.51 0.23 -80.02
Quarter Ending Dec-16 -0.31 -0.35 0.03 -11.11
Quarter Ending Sep-16 -0.42 -0.34 0.08 -19.05

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 7.54 7.19 7.73 7.73 6.63
Quarter Ending Mar-18 6.55 5.41 5.41 5.41 4.35
Year Ending Dec-17 18.85 19.23 20.32 20.32 16.61
Year Ending Dec-18 37.88 35.04 35.28 35.28 40.46
Earnings (per share)
Quarter Ending Dec-17 -0.33 -0.36 -0.37 -0.42 -0.15
Quarter Ending Mar-18 -0.26 -0.28 -0.28 -0.28 -0.25
Year Ending Dec-17 -1.83 -1.80 -1.70 -1.70 -1.14
Year Ending Dec-18 -1.08 -1.05 -1.08 -1.25 -0.56

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 1 0 2 1
Quarter Ending Mar-18 0 1 0 1
Year Ending Dec-17 0 1 1 2
Year Ending Dec-18 0 1 1 2
Earnings
Quarter Ending Dec-17 1 0 2 1
Quarter Ending Mar-18 1 0 1 0
Year Ending Dec-17 0 1 1 1
Year Ending Dec-18 1 0 2 1